• Les progrès de la recherche sont l'unique espoir pour les patients de trouver des thérapies efficaces!

  • Soutenez la recherche dans le domaine des maladies génétiques rares!

Call for applications

Eligible are research projects focused on improving treatment, care and support of the DM patient and his/her family, as well as molecular biology and basic and translational science. Deadline for submission: 6 September 2019

MDF Annual Conference

13-14 September 2019, Philadelphia
This year's conference program will include a host of sessions exploring research, drug development, disease symptom management, and provide formal and informal community networking opportunities.
CNS Outcome Measures Development Workshop: 12 September
Abstract submission until 5 July

**************************************************************

Rapport d'atelier ENMC

Protein Aggregate Myopathies
24-26 May 2019
disponible en français

Developing guidelines for management of reproductive options for families with maternally inherited mtDNA disease
22-24 March 2019
disponible en français

Diagnosis and management of Juvenile Myasthenia Gravis
1-3 March 2019
disponible en anglais

************************************************************

Job opportunity

One post-doctoral position is available at the Medical Faculty, University of Geneva, in the group of Prof. Perrine Castets that will be started in September 2019. The main interests of the group are to understand the molecular mechanisms underlying the loss of muscle function in systemic conditions and neuromuscular diseases.

More information
********************************************************

Job opportunity

Positions will be available for MSc and PhD studentships, postdoctoral fellows and research associates (lab-based and clinical) at The Ottawa Hospital and University of Ottawa Faculty of Medicine, Canada – please contact us if you are interested in joining the team.

Email us to find out more
Website

****************************************************************

5th Ottawa International Conference on Neuromuscular Disease and Biology

Ottawa, 17-19 October 2019

The conference will offer an outstanding program emphasizing recent breakthroughs in basic and translational research and clinical discoveries in neuromuscular disease.
Abstracts submission and early bird deadline: August 2nd

Skeletal muscle PGC-1α1 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance.

Agudelo LZ, Ferreira DMS, Dadvar S, Cervenka I, Ketscher L, Izadi M, Zhengye L, Furrer R, Handschin C, Venckunas T, Brazaitis M, Kamandulis S, Lanner JT, Ruas JL.
Nat Commun. 2019 Jun 24;10(1):2767

24 juin 2019

Structural Transition, Function and Dysfunction of TDP-43 in Neurodegenerative Diseases.

Afroz T, Pérez-Berlanga M, Polymenidou M.
Chimia (Aarau). 2019 May 29;73(6):380-390.

01 juin 2019

Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA.

Donadon I, Bussani E, Riccardi F, Licastro D, Romano G, Pianigiani G, Pinotti M, Kostantinova P, Evers M, Lin S, Rüegg MA, Pagani F.
Nucleic Acids Res. 2019 May 25. pii:gkz469.

31 mai 2019

Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors.

Lukjanenko L, Karaz S, Stuelsatz P, Gurriaran-Rodriguez U, Michaud J, Dammone G, Sizzano F, Mashinchian O, Ancel S, Migliavacca E, Liot S, Jacot G, Metairon S, Raymond F, Descombes P, Palini A,...

30 mai 2019